Riskpilot← Back to searchSign inGet full accessTHERMO FISHER DIAGNOSTICS AS
ASActiveOrg 986400990Ullernchaussén 52, 0379 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 200410 employees
Revenue 2024
NOK 126,2M
-5% vs 2023
EBITDA margin
4.9%
+88% vs 2023
Equity ratio
51.7%
Financial strength
Net profit 2024
NOK 3,9M
+111% vs 2023
| Revenue | NOK 126,2M | -5% |
| EBITDA | NOK 6,1M | +88% |
| Net profit | NOK 3,9M | +111% |
| Total assets | NOK 54,4M | -25% |
| Equity | NOK 28,1M | +16% |
| Employees | 10 | — |
Legal name
THERMO FISHER DIAGNOSTICS AS
Org number
986400990
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. januar 2004
Share capital
NOK 100 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Salg, markedsføring og distribusjon av produkter til bruk i laboratorium og andre lignende produkter, samt hertil knyttet virksomhet.
Address
Ullernchaussén 52, 0379 Oslo
Phone
+4723039690
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 128 341 | 130 551 | 123 395 | 132 903 | 126 185 |
| Staff expenses | −13 352 | −0 | −0 | −0 | −0 |
| EBITDA | 5 755 | 7 683 | 1 431 | 3 259 | 6 141 |
| Depreciation & amort. | −3 052 | −2 912 | −989 | −347 | −1 147 |
| EBIT | 2 704 | 4 771 | 442 | 2 912 | 4 994 |
| Net financials | −516 | −776 | −944 | −503 | 116 |
| Profit before tax | 2 187 | 3 995 | −502 | 2 409 | 5 110 |
| Tax | 500 | −0 | −0 | −0 | −0 |
| Net profit | 1 687 | 3 090 | −564 | 1 858 | 3 928 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 36 123 | 42 618 | 47 275 | 72 561 | 54 367 |
| Equity | 4 717 | 7 808 | 22 339 | 24 197 | 28 125 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 31 406 | 34 811 | 24 936 | 48 364 | 26 242 |
| Total debt | 31 406 | 34 811 | 24 936 | 48 364 | 26 242 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20202024
Equity ratio
51.7%
This company
38.2%
Market median
+35% vs market
20202024
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20202024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20202024
Asset turnover
2.32×
This company
1.12×
Market median
+107% vs market
20202024
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AO Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
JV Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
KJ Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Oxoid International Ltd | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of THERMO FISHER DIAGNOSTICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Viktil | Chief Executive Officer | 0 companies |
| Kari Johanne Jørgensen | Chief Executive Officer | 0 companies |
| Anne Omholt | Chief Executive Officer | 0 companies |
| Petrus Thomas Adrianus Van Der Zande | Chairman | 0 companies |
| Sara Maria Carrella | Board of Directors | 0 companies |
| Lynn Gray | Board of Directors | 0 companies |